Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Take Tell Us What YOU Think! Take The Body's Visitor Survey!
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

National News

St. Louisan with HIV Is Fighting Off AIDS

September 25, 2002

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Scientists at the National Institute of Allergy and Infectious Diseases have been studying 17 people who are HIV long-term nonprogressors: A handful of individuals with HIV -- less than 1 percent -- who are not developing AIDS even though they have not undergone treatment.

One person, Steve Newsom, 41, who was devastated to learn that he had HIV, found out later that he is among the very small number of people whose immune systems manage to kill most of the HIV before it can reproduce in great numbers and compromise their health. "Here I am -- on no drugs, no meds -- doing better than anyone," Newsome said, with a mix of sadness and astonishment. "Why?"

Why indeed. According to researchers, people like Newsom hold the key to the development of HIV vaccines and more effective AIDS treatments. "For some time it's been thought that there are no individuals that can restrict HIV. This isn't true," Dr. Mark Connors, senior clinical investigator in the NIAID's Laboratory of Immunoregulation. "These individuals hold some important answers to how the immune system beats HIV."

Advertisement
Research has uncovered several explanations for why some people with HIV do not get sick or need drugs. Some are infected by a damaged or weaker strain of the virus. Some individuals have more defensive immune systems. It is also possible that a combination of infection with a weaker virus and the presence of a protective gene could make the crucial difference.

Scientists at NIAID are stepping up efforts to find out how the immune system suppresses HIV in the nonprogressors. "We want to know if we can immunize people so they can come off therapy," Connors said. "Will those people then permanently be able to restrict the virus or will the virus go on to beat the immune system again?" Researchers are unsure if nonprogressors can be reinfected by a more virulent strain of the virus or if they can infect others. So far, data indicate it would be difficult for nonprogressors to transmit the virus.

Newsom's circumstances, though promising for HIV research, are complicated by the fact that he recently was not able to suppress an infection with hepatitis B, with which he was diagnosed in 1997. There seems to be something specific about his HIV infection allowing his immune system to hold it in check. Earlier this month, NIAID researchers asked Newsom to return to the institute in Maryland every six months instead of the usual once a year.

Back to other CDC news for September 25, 2002

Previous Updates

Adapted from:
St. Louis Post-Dispatch
09.22.02; Deborah L. Shelton

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More Research on Vaccines for HIV Prevention

 

Advertisement